JPS5925325A - 癌治療剤 - Google Patents

癌治療剤

Info

Publication number
JPS5925325A
JPS5925325A JP13414582A JP13414582A JPS5925325A JP S5925325 A JPS5925325 A JP S5925325A JP 13414582 A JP13414582 A JP 13414582A JP 13414582 A JP13414582 A JP 13414582A JP S5925325 A JPS5925325 A JP S5925325A
Authority
JP
Japan
Prior art keywords
purine nucleotides
pentose
effect
cancer
antitumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP13414582A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0145450B2 (enExample
Inventor
Osamu Tamemasa
為政　脩
Masakatsu Tezuka
雅勝 手塚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Priority to JP13414582A priority Critical patent/JPS5925325A/ja
Publication of JPS5925325A publication Critical patent/JPS5925325A/ja
Publication of JPH0145450B2 publication Critical patent/JPH0145450B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP13414582A 1982-07-30 1982-07-30 癌治療剤 Granted JPS5925325A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP13414582A JPS5925325A (ja) 1982-07-30 1982-07-30 癌治療剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13414582A JPS5925325A (ja) 1982-07-30 1982-07-30 癌治療剤

Publications (2)

Publication Number Publication Date
JPS5925325A true JPS5925325A (ja) 1984-02-09
JPH0145450B2 JPH0145450B2 (enExample) 1989-10-03

Family

ID=15121515

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13414582A Granted JPS5925325A (ja) 1982-07-30 1982-07-30 癌治療剤

Country Status (1)

Country Link
JP (1) JPS5925325A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003103323A (ja) * 2001-09-27 2003-04-08 Press Kogyo Co Ltd 積層金型

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS595116A (ja) * 1982-07-01 1984-01-12 Mitsui Toatsu Chem Inc 改良制癌剤
JPS5921618A (ja) * 1982-07-13 1984-02-03 エリ−ザ−・ラパポ−ト 抗癌剤

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS595116A (ja) * 1982-07-01 1984-01-12 Mitsui Toatsu Chem Inc 改良制癌剤
JPS5921618A (ja) * 1982-07-13 1984-02-03 エリ−ザ−・ラパポ−ト 抗癌剤

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003103323A (ja) * 2001-09-27 2003-04-08 Press Kogyo Co Ltd 積層金型

Also Published As

Publication number Publication date
JPH0145450B2 (enExample) 1989-10-03

Similar Documents

Publication Publication Date Title
Von Hoff et al. Phase I clinical investigation of 1, 4-dihydroxy-5, 8-bis {{{2-[(2-hydroxyethyl) amino] ethyl} amino}}-9, 10-anthracenedione dihydrochloride (NSC 301739), a new anthracenedione
JPH02111724A (ja) アデニンヌクレオチドを有効成分とする血液および血漿中のアデノシン５’‐トリホスフェートレベルを増加させる薬剤
US4880918A (en) Arrest and killing of tumor cells by adenosine 5-diphosphate and adenosine-5-triphosphate
EP0344880B1 (en) Pharmaceutical compositions with anti-cancer activity
JPH06508846A (ja) アシル化ピリミジンヌクレオシドによる化学療法剤および抗ウイルス剤毒性の治療
Calabresi et al. Clinical and pharmacological studies with 5-iodo-2′-deoxycytidine
EP0374096B1 (de) 2',3'-Dideoxypurinnucleosid/Purinnucleosid-Phosphorylase-Inhibitor Kombinationstherapie und Zusammensetzungen dafür
DE69333699T2 (de) Pyrimidinnukleotid-vorläufer zur behandlung entzündlicher hepatitis
Abele et al. Phase II study of doxifluridine in advanced colorectal adenocarcinoma.
WO1998039013A1 (en) Composition and method for treating cancer and immunological disorders resulting in chronic conditions
JPS637164B2 (enExample)
US4914105A (en) Anti-cancer compositions for delivering 5-fluorouracil
US6365578B1 (en) Drug cominbations containing AZT
Alberto et al. A randomized comparison of doxifluridine and fluorouracil in colorectal carcinoma
KR100310121B1 (ko) 티아조푸린및리바비린을사용하는종양질환의치료방법
US4622325A (en) Anti-cancer composition for delivering 5-fluorouracil
Taylor et al. Streptozotocin therapy for metastatic insulinoma
Abele et al. Phase I Clinical Study With 5'-Deoxy-5-fluorouridine, a New Fluoropyrimidine Derivative1, 2
US4719213A (en) Anti-cancer composition for delivering 5-fluorouracil
CN118903175B (zh) 小分子药物联用在增强低氧条件下nk细胞的代谢、杀伤能力中的应用
DeWys et al. Synergistic antileukemic effect of theophylline and 1, 3-bis (2-chloroethyl)-1-nitrosourea
JPS5925325A (ja) 癌治療剤
KR100403998B1 (ko) 3-[4-히드록시-3,5-비스(3-메틸-2-부테닐)페닐]-2-프로펜산또는그생리학적으로허용되는염을유효성분으로함유한,악성종양의치료를위한항종양제
RU2144835C1 (ru) Способ лечения лимфом
JP4781624B2 (ja) Ｒａｎｔｅｓ誘導剤